List of Tables
Table 1. Global Lacosamide Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Lacosamide Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Lacosamide Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Lacosamide Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Lacosamide Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Lacosamide Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Lacosamide Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Lacosamide Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Lacosamide Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Lacosamide Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Lacosamide Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Lacosamide Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Lacosamide Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lacosamide Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Lacosamide Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Lacosamide Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Lacosamide Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Lacosamide Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Lacosamide Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Lacosamide Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Lacosamide Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Lacosamide Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Lacosamide Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Lacosamide Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Lacosamide Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Lacosamide Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Lacosamide Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Lacosamide Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Lacosamide Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Lacosamide Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Lacosamide Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Lacosamide Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Lacosamide Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Lacosamide Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Lacosamide Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Lacosamide Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Lacosamide Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Lacosamide Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Lacosamide Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Lacosamide Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Lacosamide Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Lacosamide Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Lacosamide Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Lacosamide Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Lacosamide Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Lacosamide Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Lacosamide Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Lacosamide Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Lacosamide Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Lacosamide Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Lacosamide Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Lacosamide Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Lacosamide Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Lacosamide Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Lacosamide Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Lacosamide Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Lacosamide Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Lacosamide Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Lacosamide Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Lacosamide Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Lacosamide Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Lacosamide Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Lacosamide Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Lacosamide Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Lacosamide Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Lacosamide Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Lacosamide Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Lacosamide Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. UCB Pharma Company Information
Table 71. UCB Pharma Description and Business Overview
Table 72. UCB Pharma Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. UCB Pharma Lacosamide Drugs Product
Table 74. UCB Pharma Recent Developments/Updates
Table 75. Glenmark Pharmaceuticals Company Information
Table 76. Glenmark Pharmaceuticals Description and Business Overview
Table 77. Glenmark Pharmaceuticals Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Glenmark Pharmaceuticals Lacosamide Drugs Product
Table 79. Glenmark Pharmaceuticals Recent Developments/Updates
Table 80. Camber Pharma Company Information
Table 81. Camber Pharma Description and Business Overview
Table 82. Camber Pharma Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Camber Pharma Lacosamide Drugs Product
Table 84. Camber Pharma Recent Developments/Updates
Table 85. Actavis Company Information
Table 86. Actavis Description and Business Overview
Table 87. Actavis Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Actavis Lacosamide Drugs Product
Table 89. Actavis Recent Developments/Updates
Table 90. Sandoz Company Information
Table 91. Sandoz Description and Business Overview
Table 92. Sandoz Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Sandoz Lacosamide Drugs Product
Table 94. Sandoz Recent Developments/Updates
Table 95. Teva Company Information
Table 96. Teva Description and Business Overview
Table 97. Teva Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Teva Lacosamide Drugs Product
Table 99. Teva Recent Developments/Updates
Table 100. Apotex Company Information
Table 101. Apotex Description and Business Overview
Table 102. Apotex Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Apotex Lacosamide Drugs Product
Table 104. Apotex Recent Developments/Updates
Table 105. Mylan Company Information
Table 106. Mylan Description and Business Overview
Table 107. Mylan Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Mylan Lacosamide Drugs Product
Table 109. Mylan Recent Developments/Updates
Table 110. Sun Pharma Company Information
Table 111. Sun Pharma Description and Business Overview
Table 112. Sun Pharma Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Sun Pharma Lacosamide Drugs Product
Table 114. Sun Pharma Recent Developments/Updates
Table 115. Aucta Pharma Company Information
Table 116. Aucta Pharma Description and Business Overview
Table 117. Aucta Pharma Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Aucta Pharma Lacosamide Drugs Product
Table 119. Aucta Pharma Recent Developments/Updates
Table 120. Hefei Yifan Biopharmaceuticals Company Information
Table 121. Hefei Yifan Biopharmaceuticals Description and Business Overview
Table 122. Hefei Yifan Biopharmaceuticals Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Hefei Yifan Biopharmaceuticals Lacosamide Drugs Product
Table 124. Hefei Yifan Biopharmaceuticals Recent Developments/Updates
Table 125. Jiangsu Haian Pharmaceutical Company Information
Table 126. Jiangsu Haian Pharmaceutical Description and Business Overview
Table 127. Jiangsu Haian Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Jiangsu Haian Pharmaceutical Lacosamide Drugs Product
Table 129. Jiangsu Haian Pharmaceutical Recent Developments/Updates
Table 130. CSPC Ouyi Pharmaceutical Company Information
Table 131. CSPC Ouyi Pharmaceutical Description and Business Overview
Table 132. CSPC Ouyi Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. CSPC Ouyi Pharmaceutical Lacosamide Drugs Product
Table 134. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 135. Shijiazhuang No.4 Pharmaceutical Company Information
Table 136. Shijiazhuang No.4 Pharmaceutical Description and Business Overview
Table 137. Shijiazhuang No.4 Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Shijiazhuang No.4 Pharmaceutical Lacosamide Drugs Product
Table 139. Shijiazhuang No.4 Pharmaceutical Recent Developments/Updates
Table 140. Shandong Loncom Pharmaceutical Company Information
Table 141. Shandong Loncom Pharmaceutical Description and Business Overview
Table 142. Shandong Loncom Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Shandong Loncom Pharmaceutical Lacosamide Drugs Product
Table 144. Shandong Loncom Pharmaceutical Recent Developments/Updates
Table 145. Jianmin Group Company Information
Table 146. Jianmin Group Description and Business Overview
Table 147. Jianmin Group Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Jianmin Group Lacosamide Drugs Product
Table 149. Jianmin Group Recent Developments/Updates
Table 150. Jiangxi Qingfeng Pharmaceutical Company Information
Table 151. Jiangxi Qingfeng Pharmaceutical Description and Business Overview
Table 152. Jiangxi Qingfeng Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Jiangxi Qingfeng Pharmaceutical Lacosamide Drugs Product
Table 154. Jiangxi Qingfeng Pharmaceutical Recent Developments/Updates
Table 155. Beijing Sihuan Pharmaceutical Company Information
Table 156. Beijing Sihuan Pharmaceutical Description and Business Overview
Table 157. Beijing Sihuan Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Beijing Sihuan Pharmaceutical Lacosamide Drugs Product
Table 159. Beijing Sihuan Pharmaceutical Recent Developments/Updates
Table 160. Zhejiang Huahai Pharmaceutical Company Information
Table 161. Zhejiang Huahai Pharmaceutical Description and Business Overview
Table 162. Zhejiang Huahai Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Zhejiang Huahai Pharmaceutical Lacosamide Drugs Product
Table 164. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
Table 165. Buchang Pharmaceutical Company Information
Table 166. Buchang Pharmaceutical Description and Business Overview
Table 167. Buchang Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Buchang Pharmaceutical Lacosamide Drugs Product
Table 169. Buchang Pharmaceutical Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Lacosamide Drugs Distributors List
Table 173. Lacosamide Drugs Customers List
Table 174. Lacosamide Drugs Market Trends
Table 175. Lacosamide Drugs Market Drivers
Table 176. Lacosamide Drugs Market Challenges
Table 177. Lacosamide Drugs Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Lacosamide Drugs
Figure 2. Global Lacosamide Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Lacosamide Drugs Market Share by Type: 2024 & 2031
Figure 4. Tablets Product Picture
Figure 5. Injection Product Picture
Figure 6. Oral Solution Product Picture
Figure 7. Global Lacosamide Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Lacosamide Drugs Market Share by Application: 2024 & 2031
Figure 9. Hospital and Clinic
Figure 10. Retail Pharmacies
Figure 11. Other
Figure 12. Global Lacosamide Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Lacosamide Drugs Market Size (2020-2031) & (US$ Million)
Figure 14. Global Lacosamide Drugs Sales (2020-2031) & (K Units)
Figure 15. Global Lacosamide Drugs Average Price (US$/Unit) & (2020-2031)
Figure 16. Lacosamide Drugs Report Years Considered
Figure 17. Lacosamide Drugs Sales Share by Manufacturers in 2024
Figure 18. Global Lacosamide Drugs Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Lacosamide Drugs Players: Market Share by Revenue in Lacosamide Drugs in 2024
Figure 20. Lacosamide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Lacosamide Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Lacosamide Drugs Sales Market Share by Country (2020-2031)
Figure 23. North America Lacosamide Drugs Revenue Market Share by Country (2020-2031)
Figure 24. United States Lacosamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Lacosamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Lacosamide Drugs Sales Market Share by Country (2020-2031)
Figure 27. Europe Lacosamide Drugs Revenue Market Share by Country (2020-2031)
Figure 28. Germany Lacosamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Lacosamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Lacosamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Lacosamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Lacosamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Lacosamide Drugs Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Lacosamide Drugs Revenue Market Share by Region (2020-2031)
Figure 35. China Lacosamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Lacosamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Lacosamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Lacosamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Lacosamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Lacosamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Lacosamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Lacosamide Drugs Sales Market Share by Country (2020-2031)
Figure 43. Latin America Lacosamide Drugs Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Lacosamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Lacosamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Lacosamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Colombia Lacosamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Lacosamide Drugs Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Lacosamide Drugs Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Lacosamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Lacosamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Lacosamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Lacosamide Drugs by Type (2020-2031)
Figure 54. Global Revenue Market Share of Lacosamide Drugs by Type (2020-2031)
Figure 55. Global Lacosamide Drugs Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Lacosamide Drugs by Application (2020-2031)
Figure 57. Global Revenue Market Share of Lacosamide Drugs by Application (2020-2031)
Figure 58. Global Lacosamide Drugs Price (US$/Unit) by Application (2020-2031)
Figure 59. Lacosamide Drugs Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
